SIG
Sargent Investment Group Portfolio holdings
AUM
$740M
This Quarter Return
-1.58%
1 Year Return
+41.44%
3 Year Return
+107.47%
5 Year Return
+182.16%
10 Year Return
–
AUM
$626M
AUM Growth
+$626M
(+2.4%)
Cap. Flow
+$25.8M
Cap. Flow
% of AUM
4.11%
Top 10 Holdings %
Top 10 Hldgs %
41.12%
Holding
249
New
14
Increased
125
Reduced
71
Closed
16
Top Buys
| 1 |
Palantir
PLTR
|
$4.65M |
| 2 |
Coca-Cola
KO
|
$3.46M |
| 3 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
$3.03M |
| 4 |
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
$2.9M |
| 5 |
Uber
UBER
|
$1.73M |
Top Sells
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$4.69M |
| 2 |
Energy Recovery
ERII
|
$1.39M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$1.36M |
| 4 |
Summit Therapeutics
SMMT
|
$1.35M |
| 5 |
Cohen & Steers Infrastructure Fund
UTF
|
$1.02M |
Sector Composition
| 1 | Technology | 28.09% |
| 2 | Financials | 12.52% |
| 3 | Healthcare | 7.86% |
| 4 | Industrials | 4.94% |
| 5 | Consumer Discretionary | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THW
226
abrdn World Healthcare Fund
THW
$477M
| $115K | 0.02% |
10,000
| – | – |
|
227
Transocean
RIG
$2.82B
| $71.3K | 0.01% |
22,500
-155
| -0.7% | -$491 |
|
228
Lucid Diagnostics
LUCD
$126M
| $64.8K | 0.01% |
43,500
-498,000
| -92% | -$742K |
|
229
Cemex
CX
$13.3B
| $61.7K | 0.01% |
+11,000
| New | +$61.7K |
|
230
TeraWulf
WULF
$3.52B
| $55.2K | 0.01% |
20,225
-197,615
| -91% | -$539K |
|
231
Matinas BioPharma
MTNB
$10.1M
| $21.7K | ﹤0.01% |
41,800
-22,400
| -35% | -$11.6K |
|
232
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $13.5K | ﹤0.01% |
16,670
-7,615
| -31% | -$6.15K |
|
233
Ocean Power Technologies
OPTT
$92.1M
| $12.8K | ﹤0.01% |
28,000
-500,000
| -95% | -$228K |
|
|
CDMO
234
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-377,694
| Closed | -$4.69M |
|
|
XYZ
235
Block, Inc.
XYZ
$46.2B
| – | – |
-3,649
| Closed | -$299K |
|
236
Wyndham Hotels & Resorts
WH
$6.57B
| – | – |
-2,020
| Closed | -$204K |
|
237
Vanguard Mid-Cap Value ETF
VOE
$18.6B
| – | – |
-1,963
| Closed | -$315K |
|
238
Tarsus Pharmaceuticals
TARS
$2.44B
| – | – |
-4,465
| Closed | -$210K |
|
239
Rackspace Technology
RXT
$311M
| – | – |
-20,150
| Closed | -$46.7K |
|
240
Relmada Therapeutics
RLMD
$48.8M
| – | – |
-11,670
| Closed | -$4.72K |
|
241
Outset Medical
OM
$245M
| – | – |
-14,171
| Closed | -$11.4K |
|
242
Novavax
NVAX
$1.2B
| – | – |
-50,775
| Closed | -$437K |
|
243
Nerdy
NRDY
$159M
| – | – |
-100,000
| Closed | -$153K |
|
244
Liberty Latin America Class C
LILAK
$1.61B
| – | – |
-11,075
| Closed | -$68.9K |
|
|
DEA
245
Easterly Government Properties
DEA
$1.03B
| – | – |
-21,065
| Closed | -$238K |
|
246
Churchill Downs
CHDN
$7.12B
| – | – |
-1,790
| Closed | -$229K |
|
247
Carnival Corp
CCL
$42.5B
| – | – |
-32,896
| Closed | -$786K |
|
248
Boeing
BA
$176B
| – | – |
-1,256
| Closed | -$214K |
|
249
Athira Pharma
ATHA
$15.5M
| – | – |
-10,918
| Closed | -$5.8K |
|